Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 369

    1.

    Pragmatic classification of superficial neoplastic colorectal lesions.

    Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G.

    Gastrointest Endosc. 2009 Oct 29. [Epub ahead of print] No abstract available. PMID: 19879563 [PubMed - as supplied by publisher]Related articles

    2.

    Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: A study from the colon cancer family registry.

    Lindor NM, Yang P, Evans I, Schowalter K, De Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B, Hopper J, Jass J, Jenkins M, Templeton A, Potter J, Newcomb PA, Lemarchand L, Grove J, Haile R, Baron J, Seminara D, Limburg P, Thibodeau SN.

    Mol Genet Metab. 2009 Sep 27. [Epub ahead of print]PMID: 19853488 [PubMed - as supplied by publisher]Related articles

    3.

    HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.

    Walsh MD, Dent OF, Young JP, Wright CM, Barker MA, Leggett BA, Bokey L, Chapuis PH, Jass JR, Macdonald GA.

    Int J Cancer. 2009 Sep 1;125(5):1231-7.PMID: 19462453 [PubMed - indexed for MEDLINE]Related articles

    4.

    High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.

    Chong G, Jarry J, Marcus V, Thiffault I, Winocour S, Monczak Y, Drouin R, Latreille J, Australie K, Bapat B, Gordon PH, Giguère Y, Gologan A, Galiatsatos P, Jass JR, Wong N, Zaor S, Palma L, Kasprzak L, Tischkowitz M, Foulkes WD.

    Hum Mutat. 2009 Aug;30(8):E797-812.PMID: 19459153 [PubMed - indexed for MEDLINE]Related articles

    5.

    The association of tumor microsatellite instability phenotype with family history of colorectal cancer.

    Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D; Colon Cancer Family Registry.

    Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):967-75. Epub 2009 Mar 3.PMID: 19258475 [PubMed - indexed for MEDLINE]Related articles

    6.

    Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.

    Walsh MD, Buchanan DD, Walters R, Roberts A, Arnold S, McKeone D, Clendenning M, Ruszkiewicz AR, Jenkins MA, Hopper JL, Goldblatt J, George J, Suthers GK, Phillips K, Young GP, Macrae F, Drini M, Woods MO, Parry S, Jass JR, Young JP.

    Fam Cancer. 2009;8(4):313-23. Epub 2009 Feb 25.PMID: 19241144 [PubMed - in process]Related articles

    7.

    Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

    Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC; CAPP2 Investigators.

    N Engl J Med. 2008 Dec 11;359(24):2567-78. Erratum in: N Engl J Med. 2009 Apr 2;360(14):1470. PMID: 19073976 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    In vitro analysis of inflammatory responses following environmental exposure to pharmaceuticals and inland waters.

    Khalaf H, Salste L, Karlsson P, Ivarsson P, Jass J, Olsson PE.

    Sci Total Environ. 2009 Feb 1;407(4):1452-60. Epub 2008 Nov 26.PMID: 19038416 [PubMed - indexed for MEDLINE]Related articles

    9.

    Nonpolypoid neoplastic lesions of the colorectal mucosa.

    Kudo S, Lambert R, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Triadafilopoulos G, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Vieth M, Jass JR, Hurlstone PD.

    Gastrointest Endosc. 2008 Oct;68(4 Suppl):S3-47. Review. No abstract available. PMID: 18805238 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype.

    English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG.

    Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1774-80.PMID: 18628431 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.

    Liljegren A, Barker G, Elliott F, Bertario L, Bisgaard ML, Eccles D, Evans G, Macrae F, Maher E, Lindblom A, Rotstein S, Nilsson B, Mecklin JP, Möslein G, Jass J, Fodde R, Mathers J, Burn J, Bishop DT.

    J Clin Oncol. 2008 Jul 10;26(20):3434-9.PMID: 18612159 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Colorectal polyposes: from phenotype to diagnosis.

    Jass JR.

    Pathol Res Pract. 2008;204(7):431-47. Epub 2008 Jun 9. Review.PMID: 18541388 [PubMed - indexed for MEDLINE]Related articles

    13.

    MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells.

    Baker K, Foulkes WD, Jass JR.

    Cancer Immunol Immunother. 2009 Jan;58(1):135-44. Epub 2008 May 17.PMID: 18488217 [PubMed - indexed for MEDLINE]Related articles

    14.

    Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.

    Zlobec I, Terracciano L, Tornillo L, Günthert U, Vuong T, Jass JR, Lugli A.

    Gut. 2008 Oct;57(10):1413-9. Epub 2008 Apr 24.PMID: 18436576 [PubMed - indexed for MEDLINE]Related articles

    15.

    Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management.

    East JE, Saunders BP, Jass JR.

    Gastroenterol Clin North Am. 2008 Mar;37(1):25-46, v. Review.PMID: 18313538 [PubMed - indexed for MEDLINE]Related articles

    16.

    Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.

    Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, Bond CE, Simms LA, Pike T, Young JP, Jass JR, Spring KJ, Leggett BA, Whitehall VL.

    Genes Chromosomes Cancer. 2008 Jun;47(6):449-60.PMID: 18311777 [PubMed - indexed for MEDLINE]Related articles

    17.

    Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.

    Walsh MD, Cummings MC, Buchanan DD, Dambacher WM, Arnold S, McKeone D, Byrnes R, Barker MA, Leggett BA, Gattas M, Jass JR, Spurdle AB, Young J, Obermair A.

    Clin Cancer Res. 2008 Mar 15;14(6):1692-700. Epub 2008 Feb 29.PMID: 18310315 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry.

    Yeoman A, Young J, Arnold J, Jass J, Parry S.

    N Z Med J. 2007 Nov 30;120(1266):U2827.PMID: 18264196 [PubMed - indexed for MEDLINE]Related articles

    19.

    Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.

    Zlobec I, Vuong T, Compton CC, Lugli A, Michel RP, Hayashi S, Jass JR.

    Br J Cancer. 2008 Jan 29;98(2):450-6. Epub 2008 Jan 8.PMID: 18182986 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.

    Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.

    Clin Cancer Res. 2008 Jan 1;14(1):143-8.PMID: 18172264 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...